The respiratory NTM world map (TBNET#28)

J. Van Ingen (Nijmegen, Netherlands)

Source: Annual Congress 2013 –TBNET 2013: latest results
Session: TBNET 2013: latest results
Session type: Symposium
Number: 1774

Slide presentationMultimedia files

Rating: 3
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Van Ingen (Nijmegen, Netherlands). The respiratory NTM world map (TBNET#28). Annual Congress 2013 –TBNET 2013: latest results

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Seasonal distribution of acute respiratory tract infections (RTIs) due to respiratory syncytial virus (RSV), to Mycoplasma pneumonia (MP) and to Chlamydia pneumonia (CP)
Source: Eur Respir J 2001; 18: Suppl. 33, 234s
Year: 2001

Lower respiratory tract infection (LRTI): are there differences of microbial spectrum in stable phase (SP) of COPD and during acute exacerbation (AE)?
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009


GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide
Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives
Year: 2019


An outbreak of pneumococcal-chlamydial pneumonia and acute respiratory disease (ARD) among trainees
Source: Eur Respir J 2001; 18: Suppl. 33, 464s
Year: 2001

The pattern of respiratory disease in Europe
Source: Annual Congress 2013 –ERS White Book of Respiratory Medicine in Europe 2013
Year: 2013


New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Year: 2020


Low respiratory tract infection (LRTI) in ALS patients. A regional referring centre experience
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Spread of carriage of pneumonia and acute respiratory diseases (ARS) agents in recruits
Source: Eur Respir J 2005; 26: Suppl. 49, 144s
Year: 2005

Bacterilogical profile of community acquired pneumoniae (CAP) in a respiratory disease department in Tunisia
Source: Eur Respir J 2006; 28: Suppl. 50, 1s
Year: 2006

Cases series on nontuberculous mycobacterial (NTM) lung disease and silicosis in Brazil
Source: International Congress 2017 – Case reports and series
Year: 2017


A possible association between breast cancer, bronchiectasis and nontuberculous mycobacterial (NTM) lung disease
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Risk of disease and latent infection among contacts of pulmonary and pleural tuberculosis in santarem (Portugal)
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Trends in mortality from lower respiratory tract infections in Greece (1998-2015)
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


Who is the ideal candidate for telepneumology (TP) in chronic respiratory failure and MV? A European survey
Source: Eur Respir J 2006; 28: Suppl. 50, 369s
Year: 2006

Mortality due to the diseases of the respiratory system and tuberculosis in Romania
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004

Non-tuberculous mycobacteria (NTM) in bronchiectasis - a difficult management problem
Source: Eur Respir J 2003; 22: Suppl. 45, 515s
Year: 2003

Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004

Cardiac diseases in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

The sarcoidosis-tuberculosis (TB) link: molecular evidence from a high (TB) prevalence country
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009